Перейти к содержанию

Solventum Corp (SOLV) stock: revenue, earnings & dividend

Solventum Corp (SOLV, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener SOLV · NYSE Medizintechnik & Messgeräte US-MN

Key figures

Fiscal year
2025
Revenue
8.33 bn $
Revenue growth
0.9 %
Revenue growth 5y (p.a.)
–
Net income
1.56 bn $
Net margin
18.7 %
Operating margin
26.2 %
Earnings per share (diluted)
8.88 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
14.3 bn $
Equity
5.05 bn $
Equity ratio
35.3 %
Return on equity
30.8 %
Cash
878 m $
Operating cash flow
369 m $
Free cash flow
-10 m $
Shares outstanding
169,739,335

History

Revenue by fiscal year

2022 8.13 bn $
2023 8.2 bn $
2024 8.25 bn $
2025 8.33 bn $

Net income by fiscal year

2022 1.34 bn $
2023 1.35 bn $
2024 479 m $
2025 1.56 bn $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20258.33 bn $1.56 bn $8.88 $–369 m $
20248.25 bn $479 m $2.76 $–1.19 bn $
20238.2 bn $1.35 bn $7.79 $–1.92 bn $
20228.13 bn $1.34 bn $7.78 $–1.68 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)